false
0001493137
0001493137
2025-09-23
2025-09-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported): September
23, 2025
LIFELOC TECHNOLOGIES,
INC.
(Exact name of registrant
as specified in its charter)
Colorado |
|
000-54319 |
|
84-1053680 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification Number) |
12441 West 49th Ave., Unit 4 |
|
|
Wheat Ridge, CO |
|
80033 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(303) 431-9500
(Registrant’s
telephone number, including area code)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered
pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock |
LCTC |
N/A |
Indicate by check
mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 | Regulation FD Disclosure. |
On
September 23, 2025, Lifeloc Technologies, Inc. released a press release titled “Lifeloc to Present at Emerging Growth Conference
on September 25, 2025”.
A
copy of the press release is furnished herewith as Exhibit 99.1. Neither the press release nor the contents of any websites linked therein
shall be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section, nor shall be deemed incorporated by reference herein or in any other filing under the Securities Act
of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 |
Financial Statements and Exhibits. |
|
|
(d) Exhibits.
Exhibit No. |
Description |
|
|
10.1 |
Press Release, dated September 23,
2025, issued by the Company |
|
|
104 |
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
|
|
SIGNATURES
Pursuant to the
requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 23, 2025 |
LIFELOC TECHNOLOGIES, INC. |
|
|
|
|
By: |
/s/ Wayne R. Willkomm |
|
|
Wayne R. Willkomm, PhD.
President and Chief Executive Officer |